Prolaris
Prolaris® is a molecular diagnostic test that helps determine the aggressiveness of a prostate cancer tumor to guide the best treatment decisions for prostate cancer patients.
mutation createOrder {
createOrder(
order: {
billing: { institution: { institutionalAccountNumber: "123456789" } }
clinical: { ancestry: [ASHKENAZI_JEWISH], personalCancerHistory: [] }
patient: {
address: {
city: "New York"
postalCode: "10001"
stateCode: NY
street: "Example St."
}
dob: "1968-08-01"
emailAddress: "john@schmo.com"
firstName: "John"
genderCode: MALE
lastName: "Schmo"
mobilePhoneNumber: "415-555-5555"
}
products: [{ product: PROLARIS }]
providerAccounts: [
{
provider: {
identifiers: [{ type: NPI, use: OFFICIAL, value: "12345" }]
firstName: "Test"
lastName: "Provider"
}
location: {
address: {
city: "New York"
postalCode: "10001"
stateCode: NY
street: "Example St."
}
}
organization: {
identifiers: [{ type: XX, use: OFFICIAL, value: "12345" }]
}
role: ORDERING
}
]
requisitionNumber: "a1b2c3d4e5f6"
specimens: [
{
tumor: {
collectionDate: "2024-01-09"
currentTreatment: [CHEMOTHERAPY]
hospitalizationCode: NON_HOSPITAL_PATIENT
specimenIds: ["VIA-12-7589"]
tissueTypeCode: PROSTATE
tumorStage: I
prostateTumorStage: T1A
tumorHistory: {
prostate: {
currentlyBeingTreated: true
diagnosisAge: 55
diagnosisDetails: {
gleasonScore: THREE_PLUS_THREE_EQUAL_SIX
gleasonPrimaryGrade: 3
gleasonSecondaryGrade: 3
preBiopsyPSA: 8.4
biopsyCoresBiopsied: 12
biopsyCoresPositives: 4
preBiopsyTreatment: false
additionalHistopathology: ADENOCARCINOMA
}
}
}
}
}
]
}
) {
id
}
}